| Literature DB >> 35909630 |
W Utembe1,2, N Tlotleng3, A W Kamng'ona4.
Abstract
Some nanomaterials (NMs) have been shown to possess antimicrobial activity and cause GM dysbiosis. Since NMs are being used widely, a systematic assessment of the effects of NMs on GM is warranted. In this systematic review, a total of 46 in vivo and 22 in vitro studies were retrieved from databases and search engines including Science-Direct, Pubmed and Google scholar. Criteria for assessment of studies included use of in vitro or in vivo studies, characterization of NMs, use of single or multiple doses as well as consistency of results. GM dysbiosis has been studied most widely on TiO2, Ag, Zn-based NMs. There was moderate evidence for GM dysbiosis caused by Zn- and Cu-based NMs, Cu-loaded chitosan NPs and Ag NMs, and anatase TiO2 NPs, as well as low evidence for SWCNTs, nanocellulose, SiO2, Se, nanoplastics, CeO2, MoO3 and graphene-based NMs. Most studies indicate adverse effects of NMs towards GM. However, more work is required to elucidate the differences on the reported effects of NM by type and sex of organisms, size, shape and surface properties of NMs as well as effects of exposure to mixtures of NMs. For consistency and better agreement among studies on GM dysbiosis, there is need for internationally agreed protocols on, inter alia, characterization of NMs, dosing (amounts, frequency and duration), use of sonication, test systems (both in vitro and in vivo), including oxygen levels for in vitro models.Entities:
Keywords: Dysbiosis; Exposure; Gut microbiota; Metabolic disease; Nanomaterials
Year: 2022 PMID: 35909630 PMCID: PMC9325792 DOI: 10.1016/j.crmicr.2022.100118
Source DB: PubMed Journal: Curr Res Microb Sci ISSN: 2666-5174
Criteria for the assessment of the strength of the included studies
| Score | Description |
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 |
Significance of the quality of evidence for conclusion statements (adapted from Debia et al. (2016)
| Quality | Description |
| High | Strong evidence from numerous studies with consistent results. Further studies are unlikely to change the confidence in the conclusion statement |
| Moderate | Overall moderately to highly strong evidence and/or possible inconsistency in results. Further studies may change the confidence in the conclusion statement |
| Low | Overall weak evidence or inconsistency in results from a limited number of studies. Further research is very likely to change the confidence in the conclusion statement: based on |
Fig. 1Flow Diagram of Study Selection
Summary of effects of NMs on GM from in vivo tests
| Nanomaterial | Species | Exposure | Effects on GM | Evidence score | Reference |
|---|---|---|---|---|---|
| SWCNTs(1.04 – 1.17nm x 1-5 µm) | Mice | Oral administration of 0, 0.05, 0.5, and 2.5 mg/kg bwt/d for 7 days | Dose-dependent increases in the abundance of proinflammatory bacteria as well as significant shifts of | 5 | |
| MWCNTs (49-74 nm x 3.86-5.7 µm) | Mice | Oral and pulmonary administration of 0, 4, 40 mg/week for 10 weeks | No changes in the composition of GM | 4 | |
| Fullerenol 100 nm and 90 nm | Mice | 0 and 20 mg/kg per day by gavage, for a month | A shift in the overall structure of GM; a marked increase in bacteria belonging to putative SCFAs-producing genera | 3 | |
| Fullerenes (size not stated) | Rats | Dietary 0 and 5 mg/kg b.w day, 12 weeks | Shift in GM structure towards the bacteria that ameliorate lipid homeostasis | 2 | |
| Nanocellulose (50 nm) | Rats | 0 or 10 ml/kg bw of 1% twice weekly for five weeks by gavage | Enrichment of specific species and reductions in populations of species that produce large amounts of SCFAs | 3 | |
| TiO2 (29 nm anatase) | Rats | Oral administration of 0, 2, 10, 50 mg/ kg daily for 30 days | Dose-dependent GM dysbiosis | 5 | |
| TiO2 (29 nm anatase nm) | Rats | Oral administration of 0, 2, 10, 50 mg/ kg daily for 90 days | Dose-dependent increases in the abundance of | 5 | |
| TiO2 (anatase 16.8 nm | Mice | 0, 2.5 mg/kg bw/day for 7 days by oral gavage | No obvious GM dysbiosis | 3 | |
| TiO2 (220 nm and 255 nm, 85% anatase, 15% rutile) | Rats | 0, 10 mg/kg bw/day for 7 days by intragastric gavage | No obvious GM dysbiosis | 3 | |
| Rutile (16, 148, and 361 nm) and anatase (20, 135 and 420 nm)TiO2 | Mice | 0, 100 mg/kg/day for 28 days by gavage | More pronounced shift in GM structures for rutile | 3 | |
| 30 nm TiO2 NPs (majority anatase) | Mice | 0, 40 mg/kg by oral gavage for 8 weeks | Changes in composition of GM | 3 | |
| Food-grade TiO2 (28-1,158 nm) | Mice | 0, 2, 10 and 50 mg/kg/day in drinking water for 4 weeks | Minimal impact on the composition of GM. | 5 | |
| TiO2 (10 nm primary size, undefined crystal structure) | Zebra fish | Three months exposure to aquatic 100 µg/L TiO2 NPs and BPA (0, 2, and 20 µg/L) | Antagonistic interaction at the lower BPA concentration but synergistic interaction at higher BPA concentrations. | 2 | |
| TiO2 NPs (10-65 nm mixed anatase and rutile) | Aquatic 0, 100 μg/L for 4 days | Decreases in the abundance of some genera but increases in others | 3 | ||
| TiO2 (anatase, 10, 50, and 100 nm) | Mice | Dietary exposure of 0.1% for 3 months, ad libitum | Significant decrease in the abundance of several probiotic taxa | 3 | |
| TiO2 NPs (anatase <100 nm) | Mice | Oral 1 mg/kg bw /day for 7 days | Altered GM composition including a reduced richness of | 3 | |
| TiO2 NPs (food-grade from chocolates) | White albino mice | Ingestion of 0, 50 and 100 µg/day for 18 days | Inhibited growth and activity of probiotic formulation of | 5 | |
| TiO2 NPs (6–10 nm anatase) | Silkworm ( | Ingestion of 0 and 5 mg/L | Changes in the abundance of individual bacterial species | 3 | |
| Ag (12.2 nm) | Mice | Oral gavage of 0, 2.5 mg/kg bw/day for 7 days | Shifts in inter- and intra- phyla abundance of | 3 | |
| Ag (55 nm) | Mice | Dietary 0-4600 ppb (0-1140 µg/kg b.w./d) for 28 days | Disturbance in α-diversity) and β-diversity | 5 | |
| Ag (50 nm nanosheres and 45 nm nanocubes) coated with PVP | Rats | Oral administration of 0, 3.6 mg/kg b.w./day for two weeks | Nanocubes caused decreases in | 3 | |
| Ag NPs (10, 75 and 110 nm) | Rats | Oral gavage of 0, 9, 18 and 36 mg/kg bw/day for 13 weeks | Size- and dose-dependent changes to ileal mucosal microbial populations, as well as an apparent decrease in | 5 | |
| Ag NPs (20 and 110 nm PVP and citrate-coated) | Mice | Oral gavage of 0, 10 mg/kg bw/day for 28 days | No effect on the membership, structure, or diversity of GM | 3 | |
| Ag NPs (<100 nm) | Zebra fish | 0, 500 mg/kg in food for 14 days | Minor changes in community richness and diversity as the controls | 3 | |
| Ag NPs (14 nm, PVP stabilized) | Rats | Oral gavage of 0, 2.25, 4.5 or 9 mg/kg bw/day for 28 days | No effect on the balance between the two main phyla of gastrointestinal tract bacteria, | 5 | |
| Ag NPs (55 nm) | Zebra fish | Aquatic Ag NPs (0, 10, 33 or 100 μg L−1) for 35 days. | Significantly altered GM compositions in male zebrafish, but not in females | 5 | |
| Ag NPs | Varying aquatic doses from 10 μg/ml to 9000 μg/mL | Reduction in the diversity of the GM of larvae with a rise in the predominance of | 5 | ||
| Ag NPs | Lepidopteran pest | Aquatic 1.0, 0.1, 0.01 and 0.001 g/mL for 21 days | Very significant reductions in | 5 | |
| Ag NPs | Earth worm | 0, 10, 26, 64, 160 and 400 mg/kg dry soil | significant negative effect on the relative abundance of | 5 | |
| Ag NMs (from a water filtration system) | Mice | 0.2 mL per day for 45 days by ingestion | Increase in the relative abundance of | 3 | |
| ZnO NPs (<50 nm) | Mice | 0, 26 mg/kg inter-gastric administration for 30 days | Marked changes in GM composition that was closely associated with neurobehavioral impairments and dysfunctions. | 3 | |
| ZnO NPs (23.0) nm, | Pig | Dietary 0, 600, 2000 mg/kg for 14 days. | Increases in the bacterial richness and diversity in ileum, with decreased bacterial richness and diversity in cecum and colon; | 5 | |
| ZnO NPs (30 nm) | Chicken | Dietary 0, 25, 50 and 100 mg/kg for 9 weeks. | Dose-dependent changes in bacterial richness, metabolism of glucose and some amino acids as well as choline, lactate, and methionine | 5 | |
| ZnO NPs (30 nm | Dietary 0 and 500 mg kg−1 ZnO NPs for 6 weeks | No significant effects on the intestinal microbial community | 2 | ||
| HAHp (3.0) and ZnO NPs | Mice | Oral administration of 0 and 1.0 g/kg bw for | Increases in the abundances of | 2 | |
| Zn NPs (90 nm) | Chicken | Dietary 0, 5 mg/kg of feed for 28 days | Increase in | 2 | |
| Zn NPs (30 nm) | Mice | 0, 0.5, 5, 50 mg/kg in feed for 5 days | Amelioration of GM composition responsible for in initiating and maintaining IBD | 3 | |
| Zn/Cu alloy NPs (65 nm) | Chicken | 0, 2.84 mg/kg of feed for 42 days | A slight increase in the bacteria belonging to taxa | 2 | |
| SiO2 NPs (11 nm) | Mice | Oral gavage 0, 2.5 mg/kg bw/day for 7 days | Increased microbial species richness and diversity within the intestinal tract | 3 | |
| SiO2 NPs (49 nm) | Mice | Oral administration 0, 5.0 mg/kg b.w. one every two days for five weeks | GM dysbiosis that reportedly promoted lung epithelial damage by triggering the Notch pathway | 3 | |
| Fe NPs (50 nm) | Chicken | 0, 8 mg/kg of feed for 28 days | No significant changes in GM | 2 | |
| Iron(III) oxo-hydroxidenano (10-nm) | Rats | 20 mg Fe/kg diet as Fe(II) sulfate or 20 mg Fe/kg diet as nano Fe(III). | Increase in the proportion of | 2 | |
| CuO NPs | Collembolans | 0, 100 mg Cu/kg dry soil | Reduction in both diversity and abundance of GM as well as gut-associated ARGs | 2 | |
| CuO NPs (183 nm) | Earth worms | 0, 160 mg/kg dw soil, 28 days | Negative effect on the relative abundance of | 3 | |
| CuO NPs (20 and 50 nm) | Earth worm | 0, 10, 26, 64, 160 and 400 mg/kg dry soil | The alpha-diversity of treated replicates was different from the controls | 5 | |
| CuO NPs (<50 nm) | 0 and 100 mg Cu/ kg soil (dry weight). For 21 days | Marked increases in the alpha-diversity as well as shifts in GM communities, | 2 | ||
| Cu NPs (55 nm) | Chicken | 0, 1.7 mg/kg of feed for 28 days | A decrease in | 2 | |
| Cu NPs (87nm nm) | Zebra fish | 0, 500 mg/kg in food for 14 days | Suppression of beneficial bacterial strains such as | 3 | |
| MoO3 NPs (92 nm) | Zebra fish | Aquatic 0.2 and 0.4 mg/dm3 for 7 days | Changes in intestinal GM diversity | 5 | |
| Se NPs (size not indicated) | Chicken | 0, 0.3, 0.9 and 1.5 mg/kg in feed | Increases in the abundance of beneficial bacteria, such as | 5 | |
| GR (0.5 µm x 1.6 nm) GO nanosheet (0.3 µm x 1.76 nm) and rGO (42 nm x 13 nm) | Zebra fish. | 0, 1 µg /day for 21 days, dietary exposure | Increases in the relative abundance of | 3 | |
| Graphene | Rats | Dietary 1, 10 and 100 μg/day | Changes in GM diversity and community structure, with greater effects at 1 μg/day than at 10 μg/day and 100 μg/day, | 5 | |
| GO (321.74 nm x 0-1.2 nm) | Zebra fish. | Aquatic 0.05, 0.5, and 5 mg L−1 for 25 days | Disruption of GM diversity at both phylum and genus levels, with notable increases in pathogenic bacteria, | 5 | |
| Nano-polystyrene (nanoplastic, 100 nm) | Marine fish | Aquatic 14-day exposure (0, 5.50 × 10−12, 5.50 × 10−9, 5.50 × 10−7 mg/L) | Significant changes in the proportions of | 4 | |
| Nano-polystyrene (50 – 100 nm) | Soil oligochaete | 10% soil (dry weight basis) | Significant decreases in the relative abundance of | 2 | |
| Nano-sized plastics (44 nm) | Shrimp | Aquatic 0, 50 μg/L for 21 days | Changes in GM, amino acids and fatty acids as well as microbial activities | 3 | |
| Lead-halide perovskite NPs (889 - 1206 nm) | Zebra fish | 24 hour aquatic exposure to 0, 5, 10, 50, 100 and 200 mg/L and dietary exposure (500 mg/kg) | No significant changes in GM | 5 | |
| CNFs and SDA CNFs | Mice | Oral administration 0.1% (v/v) in tap water for 28 days | Increases in Bacteroidales as well as changes in the metabolism of acyl-carnitines and fatty acids | 3 | |
| Cu-loaded chitosan NPs | Rats | Dietary 80 and 160 mg/kg bw administered for 21 days | Increase of caecal | 4 | |
| Cu-loaded chitosan NPs | Pigs | 100 mg/kg in feed | A significant decrease in the abundance of | 3 | |
| Citral-loaded nanostructured systems | Silver catfish ( | Dietary 0.25 g/kg for 21 days | Reduced total bacterial population in the fish intestine, | 3 |
Summary of effects of NMs on GM from in vitro (ex vivo) tests
| Nanomaterial | Test system | Effects | Evidence score | Reference |
|---|---|---|---|---|
| ZnO NPs (10 nm) | A continuous replicated colon containing 0.01 µg/L of ZnO for 5 days | Nonlethal, significant changes to the microbial community's phenotype | 2 | |
| CeO2 (10 nm) | A continuous replicated colon containing 0.01 µg/L of CeO2 for 5 days | Nonlethal, significant changes to the microbial community's phenotype | 2 | |
| TiO2 (27 nm, 82% anatase and 18% rutile) | A continuous replicated colon containing 3 mg/L of TiO2 for 5 days | Nonlethal, significant changes to the microbial community's phenotype | 2 | |
| TiO2 NPs (25 nm, undefined crystal structure) | A continuous Human Gut Simulator system, 100 mg/day dose for 7 days | Modest reduction in community density with no impact on community diversity and evenness. | 2 | |
| TiO2 NPs (food-grade, 25 nm) | A modest decrease in the relative abundance of the dominant | 3 | ||
| TiO2 NPs (food-grade) | Induction of some physiological alterations in the most sensitive species, and thus affecting GM composition and functioning. | 3 | ||
| TiO2 NPs (Food-grade isolated from chocolates) (40 nm) | 125–250 μg/ml for 48 hours | Inhibited the growth and activity of probiotic formulation of | 2 | |
| TiO2 NPs (industrial -252 nm, 75% anatase and 25% rutile-and food-grade- 212 nm, 98% anatase and 2% rutile) | Compositional, phenotypic, and biochemical changes in GM caused by both industrial and food-grade TiO2 NPs, with more pronounced effects elicited by the food-grade TiO2 NPs. | 2 | ||
| Se NPs (unknown size) | Significant reduction in the abundance of pathogenic | 2 | ||
| Nanostructured lipid carriers (NLC, 211 nm) | This selective eradication of | 3 | ||
| Ag NPs (11 nm), PVP-capped | Cultured GM from human stool exposed NPs at 0, 25, 100 and 200 mg/L | Reduction in gas production as well as changes in fatty acid methyl ester profiles | 2 | |
| Ag NPs (49 nm), | Static GIS1 simulator, 200 mg /mL | A decrease in | 2 | |
| Ag NPs (10 nm), citrate capped | Concentration, temperature- and time-dependent inactivation of gastrointestinal phages/virus manner | 3 | ||
| Ag NPs (30–50 nm) | Human Gut dynamic Simulator system, 100 mg/day dose for 7 days | Drastic reduction of GM population density. | 2 | |
| Ag NPs, polyethylene glycol (PEG) and glutathione (GSH) stabilized | Continuous SIMGI® simulator, 88 μg/ml of PEG-AgNPs, 20 and 61 μg/ml of GSH-Ag, for 8 days | No significant changes in the composition and metabolic activity of GM | 3 | |
| Ag NPs (14 nm), citrate-capped | No effect on the composition and diversity of fecal microflora and their metabolic profiles | 2 | ||
| Nanocellulose fibres (4–5 nm) | A bacteriostatic effect of on | 2 | ||
| SWCNTs (1–3μm) and MWCNTs (> 50 μm) | Broad-spectrum antimicrobial activity against | 1 | ||
| Graphene oxide | No adverse effect on human intestinal gram-negative | 3 |
Summary of quality of evidence by type of nanomaterial
| SWCNTs | 1 | 1 | Changes in GM, more studies required | Low |
| MWCNTs | 1 | 1 | No changes in GM, more studies required | Low |
| Fullerenes | 2 | 0 | Changes in GM, more studies required | Moderate |
| Nanocellulose | 1 | 1 | Changes in GM, more studies required | Low |
| TiO2 | ||||
| Anatase | 7 | 0 | Six studies showed dysbiosis, one study showed no obvious dysbiosis | Moderate |
| Rutile | 1 | 0 | More studies required | Low |
| Food-grade | 2 | 3 | Minimal or modest impact on the composition of GM. More studies required | Low |
| Mixed or undefined crystal structure | 4 | 3 | Modest GM dysbiosis | Low |
| Silver | 12 | 6 | Some studies indicate Ag NPs cause GM dysbiosis, while other indicate otherwise. Same results for functionalized NPs | Moderate |
| ZnO | 4 | 1 | Significant changes in GM | Moderate |
| Zn | 2 | 0 | Significant changes in GM | Moderate |
| Zn/Cu alloy | 1 | 0 | Slight changes in GM | Low |
| HAHp (3.0) and ZnO NPs | 1 | 0 | Significant changes in GM | Low |
| SiO2 | 2 | 0 | Changes in GM, more studies required | Low |
| Fe | 1 | 0 | No significant changes in GM | Low |
| Nanoparticulate Iron(III) oxo-hydroxidenano | 1 | 0 | Significant changes in GM | Low |
| CuO | 4 | 0 | Significant changes in GM | Moderate |
| Cu | 2 | 0 | Significant changes in GM | Moderate |
| Se | 1 | 1 | Significant changes in GM | Low |
| GR, GO nanosheet and rGO | 3 | 1 | Some studies indicate GM dysbiosis, others do not | Low |
| Nano-polystyrene | 2 | 0 | Significant changes in GM | Moderate |
| Nanoplastics | 1 | 0 | Changes in GM | Low |
| Lead-halide perovskite | 1 | 0 | No changes in GM | Low |
| CeO2 | 0 | 1 | Changes in GM | Low |
| MoO3 NPs | 1 | 0 | Significant changes in GM diversity | Low |
| CNFs and (SDA) and CNFs | 1 | 0 | Significant changes in GM diversity | Low |
| Cu-loaded chitosan NPs | 2 | 0 | Significant changes in GM | Moderate |
| Citral-loaded nanostructured systems comprising of nanoemulsions (NEs) and alginate NPs | 1 | 0 | Significant changes in GM | Low |
| Citral-loaded nanostructured systems | 1 | 0 | Significant changes in GM | Low |